Please sign in to follow a disease.

Platinum-resistant

Clinical trials for Platinum-resistant explained in plain language.

Never miss a new study

Get alerted when new Platinum-resistant trials appear

Sign up with your email to follow new studies for Platinum-resistant, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Not yet finished but already full! 2

New drug aimed at Hard-to-Treat ovarian cancer shows promise in trial

Disease control Recruiting now

This study tests a drug called mirvetuximab soravtansine (MIRV) in people with ovarian, peritoneal, or fallopian tube cancer that no longer responds to platinum chemotherapy and has high levels of a protein called FRα. The drug delivers a cancer-killing agent directly to tumor ce…

Matched conditions: PLATINUM-RESISTANT

Phase 2 • Sponsor: AbbVie • Aim: Disease control

Last updated Jun 27, 2026 12:38 UTC

Platinum-resistant

Get alerted when new Platinum-resistant trials appear

New drug aimed at Hard-to-Treat ovarian cancer shows promise in trial